BNP Paribas Financial Markets Makes New $234,000 Investment in Alignment Healthcare, Inc. (NASDAQ:ALHC)

BNP Paribas Financial Markets bought a new position in Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 20,821 shares of the company's stock, valued at approximately $234,000.

Other hedge funds also recently made changes to their positions in the company. Barclays PLC lifted its position in shares of Alignment Healthcare by 144.1% in the third quarter. Barclays PLC now owns 193,446 shares of the company's stock worth $2,287,000 after buying an additional 114,191 shares in the last quarter. US Bancorp DE lifted its position in shares of Alignment Healthcare by 6,544.2% in the fourth quarter. US Bancorp DE now owns 98,932 shares of the company's stock worth $1,113,000 after buying an additional 97,443 shares in the last quarter. Northern Trust Corp lifted its position in shares of Alignment Healthcare by 8.6% in the fourth quarter. Northern Trust Corp now owns 908,964 shares of the company's stock worth $10,226,000 after buying an additional 72,063 shares in the last quarter. Franklin Resources Inc. purchased a new stake in shares of Alignment Healthcare in the fourth quarter worth about $732,000. Finally, Proficio Capital Partners LLC purchased a new stake in shares of Alignment Healthcare in the fourth quarter worth about $184,000. 86.19% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In related news, President Dawn Christine Maroney sold 230,000 shares of the stock in a transaction that occurred on Monday, April 14th. The stock was sold at an average price of $19.10, for a total value of $4,393,000.00. Following the transaction, the president now owns 2,132,899 shares of the company's stock, valued at $40,738,370.90. This represents a 9.73% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Atlantic (Aln Hlth) L. General sold 17,000,000 shares of the stock in a transaction that occurred on Monday, May 19th. The stock was sold at an average price of $15.28, for a total value of $259,760,000.00. Following the completion of the transaction, the director now directly owns 44,302,175 shares in the company, valued at approximately $676,937,234. This trade represents a 27.73% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 19,166,977 shares of company stock valued at $294,801,511. 7.00% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the company. Robert W. Baird boosted their price objective on Alignment Healthcare from $17.00 to $22.00 and gave the stock an "outperform" rating in a research note on Tuesday, April 15th. Bank of America boosted their price objective on Alignment Healthcare from $15.50 to $18.50 and gave the stock a "buy" rating in a research note on Tuesday, March 4th. JPMorgan Chase & Co. boosted their price objective on Alignment Healthcare from $14.00 to $17.00 and gave the stock a "neutral" rating in a research note on Thursday, March 6th. Stifel Nicolaus boosted their price objective on Alignment Healthcare from $18.00 to $23.00 and gave the stock a "buy" rating in a research note on Tuesday, April 8th. Finally, William Blair reissued an "outperform" rating on shares of Alignment Healthcare in a research note on Friday, February 28th. One analyst has rated the stock with a sell rating, three have issued a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat.com, Alignment Healthcare currently has a consensus rating of "Moderate Buy" and a consensus target price of $17.17.

Alignment Healthcare Trading Up 0.9%

Shares of ALHC traded up $0.14 during mid-day trading on Monday, reaching $15.51. 3,431,604 shares of the company's stock traded hands, compared to its average volume of 1,986,701. The stock has a market cap of $3.07 billion, a P/E ratio of -20.14 and a beta of 1.32. The stock's 50-day moving average is $16.95 and its two-hundred day moving average is $14.74. Alignment Healthcare, Inc. has a 12 month low of $7.05 and a 12 month high of $21.06. The company has a debt-to-equity ratio of 1.82, a current ratio of 1.60 and a quick ratio of 1.60.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last released its earnings results on Thursday, May 1st. The company reported ($0.05) EPS for the quarter, beating analysts' consensus estimates of ($0.12) by $0.07. The firm had revenue of $926.93 million for the quarter, compared to analysts' expectations of $889.83 million. Alignment Healthcare had a negative return on equity of 108.69% and a negative net margin of 5.84%. The company's quarterly revenue was up 47.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($0.25) earnings per share. Research analysts forecast that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.